{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:04:23Z","timestamp":1747109063970,"version":"3.40.5"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>For many patients, weight loss is a first-line measure recommended to reduce comorbidities associated with polycystic ovary disease. When lifestyle modifications such as diet and exercise are insufficient at achieving this goal, the addition of weight loss medications has proven effective for many patients. In patients with severe obesity, bariatric surgery is often used when other methods have been unsuccessful and has shown promising results for improving health and fertility in patients with polycystic ovary disease.<\/jats:p>","DOI":"10.1097\/grf.0000000000000599","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T14:30:13Z","timestamp":1608561013000},"page":"90-95","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Polycystic Ovary Disease and Obesity: Leptin, Weight-loss Medication, and Bariatric Surgery"],"prefix":"10.1097","volume":"64","author":[{"given":"JENNIFER M.","family":"BURGART","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ijgo.12824","article-title":"Prevalence of polycystic ovary syndrome in a metabolically healthy obese population","volume":"146","author":"Mu","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.rbmo.2018.08.007","article-title":"Metabolic characteristics of normal weight central obesity phenotype polycystic ovary syndrome women: a large-scale national epidemiological survey","volume":"37","author":"Mu","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1515\/cclm-2014-0387","article-title":"Role of leptin in female reproduction","volume":"53","author":"Perez-Perez","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ng0396-318","article-title":"Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin","volume":"12","author":"Chehab","year":"1996","journal-title":"Nat Genet"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/humrep\/16.9.1819","article-title":"Baseline non-fasting serum leptin concentration to body mass index ratio is predictive of IVF outcomes","volume":"16","author":"Brannian","year":"2001","journal-title":"Hum Reprod"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.metabol.2014.10.013","article-title":"Roles of leptin in reproduction, pregnancy and polycystic ovary syndrome: consensus knowledge and recent developments","volume":"64","author":"Vazquez","year":"2015","journal-title":"Metabolism"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/molehr\/3.6.467","article-title":"The expression of leptin and its receptors in pre-ovulatory human follicles","volume":"3","author":"Cioffi","year":"1997","journal-title":"Mol Hum Reprod"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1043-2760(00)00352-0","article-title":"Leptin in reproduction","volume":"12","author":"Caprio","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/1933719116670265","article-title":"Leptin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"24","author":"Zheng","year":"2017","journal-title":"Reprod Sci"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"423","DOI":"10.29252\/ijrm.15.7.423","article-title":"Association of leptin and insulin resistance in PCOS: a case-controlled study","volume":"15","author":"Namavar Jahromi","year":"2017","journal-title":"Int J Reprod Biomed (Yazd)"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1210\/jc.2014-1135","article-title":"Body composition is improved during 12 months\u2019 treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome","volume":"99","author":"Glintborg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.fertnstert.2019.09.011","article-title":"Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial","volume":"113","author":"Li","year":"2020","journal-title":"Fertil Steril"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.fertnstert.2007.04.043","article-title":"Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels","volume":"89","author":"Panidis","year":"2008","journal-title":"Fertil Steril"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/09513590.2012.736557","article-title":"Diet, physical exercise and Orlistat administration increase serum anti-Mullerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)","volume":"29","author":"Vosnakis","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12020-014-0426-4","article-title":"Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial","volume":"49","author":"Moini","year":"2015","journal-title":"Endocrine"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/ijcp.12787","article-title":"Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis","volume":"70","author":"Graff","year":"2016","journal-title":"Int J Clin Pract"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/obr.12720","article-title":"Pharmacologic therapy to induce weight loss in women who have obesity\/overweight with polycystic ovary syndrome: a systematic review and network meta-analysis","volume":"19","author":"Wang","year":"2018","journal-title":"Obes Rev"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/EJE-13-0797","article-title":"Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin","volume":"170","author":"Jensterle Sever","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11695-015-1902-5","article-title":"The impact of bariatric surgery on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"26","author":"Skubleny","year":"2016","journal-title":"Obes Surg"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1007\/s11695-020-04487-3","article-title":"Impact of bariatric surgery on clinical, biochemical, and hormonal parameters in women with polycystic ovary syndrome (PCOS)","volume":"30","author":"Singh","year":"2020","journal-title":"Obes Surg"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.soard.2014.02.046","article-title":"Changes in hormones and biomarkers in polycystic ovarian syndrome treated with gastric bypass","volume":"10","author":"Eid","year":"2014","journal-title":"Surg Obes Relat Dis"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09513590.2016.1236243","article-title":"The impact of gastric bypass surgery on sex hormones and menstrual cycles in premenopausal women","volume":"33","author":"Kjaer","year":"2017","journal-title":"Gynecol Endocrinol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:18:07Z","timestamp":1747063087000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000599","relation":{},"ISSN":["0009-9201"],"issn-type":[{"type":"print","value":"0009-9201"}],"subject":[],"published":{"date-parts":[[2020,12,18]]}}}